Updated: 21-Oct-25 09:09 ET
There are no IPOs scheduled for this time period.
Co: MPLT
MapLight Therapeutics (Nasdaq) | Clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system | Initial Shares: 14.8 M | Initial Range: $17.00-$17.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Morgan Stanley, Jefferies, Leerink, Stifel
Co: NAVN
Navan (NasdaqGS) | Navan is an all-in-one platform for business travel, payments, and expenses, streamlining booking, spending, and reporting with 24/7 support and an intuitive user experience | Initial Shares: 36.9 M | Initial Range: $24.00-$26.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Goldman Sachs & Co. LLC and Citigroup
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.